Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton’s tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia, a form of non-Hodgkin’s lymphoma.
Ibrutinib is used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom’s macroglobulinemia.
my contact infomation is:
Notice: This product is only suitable for laboratory use, or the use of animals. It can not be used directly on the human body